Table 1
From: PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice
|
\months ACRpedi\ | 3 (n = 55) | 6 (n = 54) | 9 (n = 51) | 12 (n = 43) | 18 (n = 33) | 24 (n = 24) | 30 (n = 9) |
|---|---|---|---|---|---|---|---|
| 30% | 51% | 13% | 2% | 2% | 0 | 4% | 0 |
| 50% | 49% | 63% | 24% | 12% | 15% | 8% | 0 |
| 70% | 0 | 24% | 55% | 44% | 24% | 17% | 11% |
| 90% | 0 | 0 | 6% | 35% | 55% | 63% | 67% |